SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

19 Jul 2024 Evaluate
The sales is pegged at Rs. 1667.00 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2174.00 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -102.00 millions as compared to Net Profit of Rs. 19.00 millions of corresponding quarter ended June 2023OP of the company witnessed a marginal growth to 207.00 millions from 201.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1667.00 2174.00 -23.32 1667.00 2174.00 -23.32 7847.00 8101.00 -3.14
Other Income 195.00 159.00 22.64 195.00 159.00 22.64 1034.00 1379.00 -25.02
PBIDT 207.00 201.00 2.99 207.00 201.00 2.99 1199.00 1410.00 -14.96
Interest 76.00 64.00 18.75 76.00 64.00 18.75 299.00 185.00 61.62
PBDT 19.00 137.00 -86.13 19.00 137.00 -86.13 900.00 1225.00 -26.53
Depreciation 131.00 114.00 14.91 131.00 114.00 14.91 483.00 432.00 11.81
PBT -112.00 23.00 -586.96 -112.00 23.00 -586.96 417.00 793.00 -47.41
TAX -10.00 4.00 -350.00 -10.00 4.00 -350.00 101.00 294.00 -65.65
Deferred Tax -10.00 0.00 0.00 -10.00 0.00 0.00 33.00 156.00 -78.85
PAT -102.00 19.00 -636.84 -102.00 19.00 -636.84 316.00 499.00 -36.67
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 12.42 9.25 34.31 12.42 9.25 34.31 15.28 17.41 -12.21

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×